Use of Maytenus Ilicifolia in the Treatment of Dyspepsia

• Status: Terminated
• Trial end date: 2016-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to evaluate the therapeutic effect of the infusion of Maytenus ilicifolia Mart. ex Reiss leaves, used for 8 weeks, on patients with dyspepsia. Primary endpoint is SODA score, secondary endpoint is endoscopic classification (Sydney).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Casa Espirita Terra de Ismael
• Collaborator: University of Sao Paulo
• Treatments: Omeprazole

Criteria

Inclusion Criteria:

• age > 18 years

• being literate

• diagnosis of dyspepsia

• initial SODA score > or = 25

Exclusion Criteria:

• pregnancy

• lactation

• allergy to Maytenus species

• fail to use the drug for 3 uninterrupted weeks

• new onset serious adverse events, attributable to the drug

• patient's request